Aim-To determine whether DNA ploidy patterns and S phase fraction offer prognostic information in patients with rhabdomyosarcoma (RMS). Methods In addition to its clinical and histopathological diversity, molecular heterogeneity has been identified by the identification of cytogenetic abnormalities, such as translocation t(2,13)(q35-37,q14)5 and loss of constitutional heterozygosity at loci on chromosome 1 lp.6 To our knowledge, however, the prognostic relevance of these markers has not yet been confirmed.
Abstract
Aim-To determine whether DNA ploidy patterns and S phase fraction offer prognostic information in patients with rhabdomyosarcoma (RMS). Methods-DNA flow cytometry was performed on formalin fixed, paraffin wax embedded samples from primary tumours, and metastatic deposits or recurrences in 70 patients. DNA histogram analysis was done using a semiautomated cell cycle analysis program. Results-Of the 70 primary tumours, 23 were DNA diploid, 32 In addition to its clinical and histopathological diversity, molecular heterogeneity has been identified by the identification of cytogenetic abnormalities, such as translocation t(2,13)(q35-37,q14)5 and loss of constitutional heterozygosity at loci on chromosome 1 lp.6 To our knowledge, however, the prognostic relevance of these markers has not yet been confirmed.
The basic characteristics of cancer cells, such as alteration in the nuclear DNA content and chromosomal aberrations, may be manifest histologically by the presence of nuclear pleomorphism, an increased nuclear cytoplasmic ratio, altered chromatin density, as well as atypical mitotic figures. Yet in RMS no attempts to quantify these morphological features have been published. In contrast, the nuclear DNA content has shown to be a quantifiable variable which correlates with prognosis in a variety of malignant diseases. [7] [8] [9] [10] Methods Clinical data and archival formalin fixed, paraffin wax embedded tissues from the primary tumour of 98 patients diagnosed for RMS between 1968 and 1991 were retrieved from the files of the Emma Kinderziekenhuis/Antoni van Leeuwenhoek Ziekenhuis Amsterdam, the Free University Hospital of Amsterdam, and the Academic Hospital of Groningen. The mean age of the children at time of diagnosis was 6 years (range 6 months to 22 years). The male female ratio was 6:5. The anatomic sites of the primary tumours included head and neck (n = 41); urogenital area and pelvis (n = 30); abdomen (n = 12); extremities (n = 9); and thorax or trunk (n = 6). Adequate information about clinical stage, according to the TNM system4 was available in 95 cases. The tumours were staged as I (n = 56), II (n = 15), III (n = 12), and IV (n = 12). The mean follow up was six years (range one month to 19 years), with a mean follow up of the surviving patients of nine years (range one to 19 years).
Haematoxylin and eosin stained slides of the tumour blocks were reviewed by a panel of paediatric pathologists (JvdL, AvU, JD) and classified into embryonal RMS (n = 53), alveolar or solid alveolar RMS (n = 17), botryoid RMS (n = 9), embryonal sarcoma (n = 6), spindle cell RMS (n = 5), and RMS not otherwise specified (n = 8)."1 The reviewing pathologists were unaware of the results of the DNA ploidy analysis.
Preparation of cell suspensions from the formalin fixed, paraffin wax embedded tumour specimens was performed according to a modified Hedley technique,'2 applying an extra digestive step on the material remaining on the mesh after the first enzymatic treatment. DNA flow cytometry of the cell suspensions was performed after DAPI (4',6'-diaminido-2-phenyl-indole dihydrochloride) staining with a mercury lamp based Pas II Analyser (Partec, Miinster, Germany).
Fibroblasts, lymphocytes, and other normal cells, always present in suspensions, were regarded as the internal standard for DNA diploid cells, depicted as the far left peak on the histogram. When only one G/GI peak was present, the tumour was classified as DNA diploid. Tumours with one additional G/Gj peak were classified as DNA aneuploid. When there was clearly more than one aneuploid G0/Gl peak, the tumour was considered DNA multiploid. DNA tetraploidy was defined when the proportion of the G2/M cells of the diploid population exceeded 10%. The DNA Index (DI) was denoted by the ratio of the modal channel number of the GO/GI peak to that of normal G/Gj cells.'3 The coefficient of variation of the first G/G, peak ranged from 3-12-7% with a mean of 6%. The average S phase fraction of tumour cell population(s) was determined by cell cycle analysis using the semi-automated Multicycle program (Phoenix Flow Systems, Philadelphia, USA). Histograms were considered evaluable when (1) at least 10 000 nuclei were analysed, (2) the coefficient of variation did not exceed 15%, and (3) tumour cells were present in stained sections taken before and after the tumour material used to prepare the cell suspension (sandwich technique).
All statistical analyses were performed using the BMDP package (BMDP Statistical Software, Los Angeles, USA). Detailed data description was computed for all features. Statistical analysis of the data was performed using X2 contingency tables. Kaplan-Meier disease free and overall survival curves were plotted, and differences between the curves were analysed using the Time (months) Figure 2 Kaplan-Meier overall survival curves for rhabdomyosarcoma patients with low (< 15%o) and high (>15%) S phase fractions. histopathological classification.
In 24 cases samples of primary tumour and those taken from relapsed tumour (recurrence/or metastasis) were analysed. Table 3 shows the major changes in the DNA ploidy pattern of the relapses-loss of stem line (figs 3A, B) or gain of new stem lines (figs 3C, D, E, F) were observed in 15 cases; two of these patients survived. Of the nine cases in which no major change in the DNA content of the relapsed tumour was observed, five patients reached long term survival (p = 0-02; X2 test). Further studies are in progress in which S phase data are being compared with proliferation markers, such as PCNA and MIB 1. 29 30 In 24 cases tissue samples from the primary tumour and relapsed tumour were available. Evaluation of the DNA ploidy showed a major change in the DNA ploidy of the relapse tissue in 15 of the 24 cases; the other nine cases showed no major changes (table  3) . The occurrence of changes in DNA ploidy pattern after chemo and radiotherapy have been described."313' In our view, these changes rely partially on tumour heterogeneity. Therefore, due to sampling error or selective proliferation of 
